ELIOR GROUP (ELIOR.PA)       3.095  +0.01 (+0.36%)

3.095  +0.01 (+0.36%)

FR0011950732 - Common Stock


Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ELIOR. ELIOR was compared to 20 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of ELIOR have multiple concerns. ELIOR has a correct valuation and a medium growth rate.

Note: ELIOR has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

ELIOR has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of ELIOR.

VS Industry

Valuation

Valuation Rating

5

ELIOR's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the current price to the book value of ELIOR, it is valued rather cheaply. It is trading at 0.69 times its book value.
When comparing the price book ratio of ELIOR to the average industry price book ratio of 1.47, ELIOR is valued rather cheaply. ELIOR is also cheaper than 86% of the companies listed in the same industry.

ELIOR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Forward Price/Earnings Ratio of 66.88, ELIOR is valued very expensively.
VS Industry

Price/Book (0.69) VS Industry: 86% outperformed.

7.74
0.47

Growth

Growth Rating

6

ELIOR is expected to show a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 28.99% yearly.
ELIOR shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.62%.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

The Revenue has been decreasing by -7.07% on average over the past 5 years.
Based on estimates for the next 5 years, ELIOR will show a small growth in Revenue. The Revenue will grow by 4.54% on average per year.
ELIOR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -341.03%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -341.03% 107.37% 60.78% 40.55% 28.99%
Revenue-7.07% -3.3% 20.62% 7.44% 6.68% 5.37% 4.54%

Health

Health Rating

2

The Altman-Z score is in line with the industry averages, which is at 0.80.
A Current Ratio of 0.75 indicates that ELIOR may have some problems paying its short term obligations.
When comparing the Current Ratio of ELIOR to the average industry Current Ratio of 0.91, ELIOR is less able to pay its short term obligations than its industry peers.
A Quick Ratio of 0.67 indicates that ELIOR may have some problems paying its short term obligations.

When comparing the Quick Ratio of ELIOR to the average industry Current Ratio of 0.87, ELIOR is less able to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.76, ELIOR is requires more financing than its industry peers. 80% of its industry peers have a better Debt to Equity Ratio.
ELIOR has an Altman-Z score of 0.80. This is a bad value and indicates that ELIOR is not financially healthy and even has some risk of bankruptcy.
ELIOR has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of ELIOR.
VS Industry

Debt/Equity (1.56) VS Industry: 20% outperformed.

5.57
0.00

Quick Ratio (0.67) VS Industry: 33% outperformed.

0.25
4.66

Current Ratio (0.75) VS Industry: 33% outperformed.

0.25
4.66

Altman-Z (0.8) VS Industry: 50% outperformed.

-5.91
3.20

Dividend

Dividend Rating

0

No dividends for ELIOR!.

ELIOR GROUP3.095

EPA:ELIOR (3/29/2023, 9:51:36 AM)+0.01 (+0.36%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap533.98M
Analysts53.64
Price Target3.63 (17.29%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)-200.97%
Min EPS beat(2)-200.97%
Max EPS beat(2)-200.97%
EPS beat(4)N/A
Avg EPS beat(4)-1931.55%
Min EPS beat(4)-3662.14%
Max EPS beat(4)-200.97%
Revenue beat(2)N/A
Avg Revenue beat(2)-1.86%
Min Revenue beat(2)-1.86%
Max Revenue beat(2)-1.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)0.95%
PT rev (1m)0%
PT rev (3m)7.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.96%
EPS NY rev (3m)-41.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 66.88
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.69
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.48
EYN/A
EPS(NY)0.05
Fwd EY1.5%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS25.8
BVpS4.47
TBVpS-5.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM 67.56%
ROICexgc(3y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc(3y)N/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.46%
F-Score3
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.83%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.67
Altman-Z 0.8
F-Score3
WACC6.46%
ROIC/WACCN/A
Cap/Depr(3y)40.2%
Cap/Depr(5y)65.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-341.03%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-244.66%
EPS Next Y107.37%
EPS Next 2Y60.78%
EPS Next 3Y40.55%
EPS Next 5Y28.99%
Revenue growth 1Y20.62%
Revenue growth 3Y-3.3%
Revenue growth 5Y-7.07%
Revenue growth Q2Q21.47%
Revenue Next Year7.44%
Revenue Next 2Y6.68%
Revenue Next 3Y5.37%
Revenue Next 5Y4.54%
EBIT growth 1Y-334.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year472.29%
EBIT Next 3Y94.65%
EBIT Next 5Y52.75%
FCF growth 1Y-258.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-190%
OCF growth 3YN/A
OCF growth 5YN/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext